Spatial resilience of forested landscapes under climate change and management

Context

Resilience, the ability to recover from disturbance, has risen to the forefront of scientific policy, but is difficult to quantify, particularly in large, forested landscapes subject to disturbances, management, and climate change.

Objectives

Our objective was to determine which spatial drivers will control landscape resilience over the next century, given a range of plausible climate projections across north-central Minnesota.

Methods

Using a simulation modelling approach, we simulated wind disturbance in a 4.3 million ha forested landscape in north-central Minnesota for 100 years under historic climate and five climate change scenarios, combined with four management scenarios: business as usual (BAU), maximizing economic returns (‘EcoGoods’), maximizing carbon storage (‘EcoServices’), and climate change adaption (‘CCAdapt’). To estimate resilience, we examined sites where simulated windstorms removed >70% of the biomass and measured the difference in biomass and species composition after 50 years.

Results

Climate change lowered resilience, though there was wide variation among climate change scenarios. Resilience was explained more by spatial variation in soils than climate. We found that BAU, EcoGoods and EcoServices harvest scenarios were very similar; CCAdapt was the only scenario that demonstrated consistently higher resilience under climate change. Although we expected spatial patterns of resilience to follow ownership patterns, it was contingent upon whether lands were actively managed.

Conclusions

Our results demonstrate that resilience may be lower under climate change and that the effects of climate change could overwhelm current management practices. Only a substantial shift in simulated forest practices was successful in promoting resilience.

     

Single‐ and multiple dose pharmacokinetics and multiple dose pharmacodynamics of oral ABT‐116 (a TRPV1 antagonist) in dogs

Six dogs were used to determine single and multiple oral dose pharmacokinetics of ABT‐116. Blood was collected for subsequent analysis prior to and at 15, 30 min and 1, 2, 4, 6, 12, 18, and 24 h after administration of a single 30 mg/kg dose of ABT‐116. Results showed a half‐life of 6.9 h, k_el of 0.1/h, AUC of 56.5 μg·h/mL, T_max of 3.7 h, and C_max of 3.8 μg/mL. Based on data from this initial phase, a dose of 10 mg/kg of ABT‐116 (no placebo control) was selected and administered to the same six dogs once daily for five consecutive days. Behavioral observations, heart rate, respiratory rate, temperature, thermal and mechanical (proximal and distal limb) nociceptive thresholds, and blood collection were performed prior to and 4, 8, and 16 h after drug administration each day. The majority of plasma concentrations were above the efficacious concentration (0.23 μg/mL previously determined for rodents) for analgesia during the 24‐h sampling period. Thermal and distal limb mechanical thresholds were increased at 4 and 8 h, and at 4, 8, and 16 h respectively, postdosing. Body temperature increased on the first day of dosing. Results suggest adequate exposure and antinociceptive effects of 10 mg/kg ABT‐116 following oral delivery in dogs.     

Effects of oral powder electrolyte administration on packed cell volume,plasma chemistry parameters,and incidence of colic in horses participating in a 6-day 162-km trail ride

This study evaluated the effects of administering oral powder electrolytes on packed cell volume (PCV), plasma chemistry parameters, and incidence of colic in horses participating on a 6-day 162-km trail ride in which water was not offered ad libitum. Twenty-three horses received grain with powder electrolytes daily while 19 control horses received grain only. Horses were ridden approximately 32 km a day at a walk or trot. Packed cell volume and plasma chemistry parameters were analyzed daily. Episodes of colic were diagnosed and treated by a veterinarian unaware of treatment group allocation. Blood parameters and incidence of colic were compared between treatment groups. Electrolyte administration did not alter PCV or plasma chemistry parameters compared to controls. The incidence of colic was significantly higher in treated horses (P = 0.05). Oral powder electrolytes did not enhance hydration status or electrolyte homeostasis and may be associated with colic in horses participating on long distance trail rides similar to this model.